Contents

Search


17-ketogenic steroids in 24 hour urine

Indications: - used in conjunction with metyrapone stimulation test Reference interval: -> adult a) male: 5-23 mg/day (17-80 umol/day) b) female: 3-15 mg/day (10-52 umol/day) Clinical significance: the test measures: 1) corticosteroids 2) their precursors a) 17-hydroxyprogesterone b) pregnane triol 2) their metabolites a) cortols b) cortolones Increases: 1) pharmaceutical agents a) in-vivo effects -> ACTH, cortisone acetate, hydrocortisone b) chemical interferences -> cephalothin, digitoxin, meprobamate, phenothiazines, naproxen (m-dinitrobenzene reagent), penicillin, spironolactone 2) clinical disorders a) Cushing's syndrome b) congenital adrenal hyperplasia c) obesity d) acute illness e) pregnancy Decreases: 1) pharmaceutical agents a) in-vivo effects -> ampicillin, dexamethasone, estrogens, phenytoin, oral contraceptives, prednisone, prednisolone b) chemical interferences -> chlordiazepoxide, glucose, meglumine 2) clinical disorders a) Addison's disease b) hypopituitarism c) hypothyroidism d) generalized wasting syndrome Method: - colorimetric (Zimmerman) Specimen: 1) urine, 24 hours 2) preserve with boric acid & refrigerate 3) stable for at least 2 weeks & for longer periods if frozen at -20 degrees C Notes: - largely replaced by specific assays of plasma & urine steroids

Related

17-hydroxycorticosteroids in 24 hour urine 17-ketosteroids in 24 hour urine metyrapone stimulation test

General

24 hour urine 17-ketogenic steroids in urine

References

Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995